A
Alliance Pharma PLC
LSE:APH
Alliance Pharma PLC
LSE:APH
Price:
33.1 GBX
-1.78%
Market Closed
Updated:
May 4, 2024
Alliance Pharma PLC
Cash from Investing Activities
|
Alliance Pharma PLC
Cash from Investing Activities Peer Comparison
Comparables:
GSK
AZN
INDV
HIK
DPH
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
A
|
Alliance Pharma PLC
LSE:APH
|
Cash from Investing Activities
-£1.4m
|
CAGR 3-Years
24%
|
CAGR 5-Years
55%
|
CAGR 10-Years
24%
|
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Cash from Investing Activities
-£1.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
AstraZeneca PLC
LSE:AZN
|
Cash from Investing Activities
-$4.1B
|
CAGR 3-Years
-142%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-3%
|
|
|
Indivior PLC
LSE:INDV
|
Cash from Investing Activities
-$98m
|
CAGR 3-Years
-190%
|
CAGR 5-Years
-90%
|
CAGR 10-Years
N/A
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Cash from Investing Activities
-$333m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
-11%
|
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Cash from Investing Activities
-£426.2m
|
CAGR 3-Years
-74%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-36%
|
See Also
What is Alliance Pharma PLC's Cash from Investing Activities?
Cash from Investing Activities
-1.4m
GBP
-1.4m
GBP
Based on the financial report for Jun 30, 2023, Alliance Pharma PLC's Cash from Investing Activities amounts to -1.4m GBP.
What is Alliance Pharma PLC's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
24%
24%
Over the last year, the Cash from Investing Activities growth was 92%. The average annual Cash from Investing Activities growth rates for Alliance Pharma PLC have been 24% over the past three years , 55% over the past five years , and 24% over the past ten years .
You don't have any saved screeners yet
